HomeInsightsPE

Bliss Gvs Pharma Ltd PE Ratio

Bliss Gvs Pharma Ltd PE Ratio

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

48.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

PE

16.5

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Bliss GVS Pharma Ltd is 16.5 as of 22 Nov 15:30 PM .
  • The P/E Ratio of Bliss GVS Pharma Ltd changed from 15 on March 2019 to 15.6 on March 2024 . This represents a CAGR of 0.66% over 6 years.
  • The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 131.5 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Bliss GVS Pharma Ltd

No data available

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Share Price

₹ 131.5

2.50 (1.94%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024131.5
21 Nov 2024129
19 Nov 2024120.75
18 Nov 2024121.65
14 Nov 2024117.95
13 Nov 2024116.35
12 Nov 2024118.7
11 Nov 2024121.2
08 Nov 2024124.15
07 Nov 2024126.55

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bliss GVS Pharma Ltd161,384
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Bliss GVS Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bliss GVS Pharma Ltd

No data available

* All values are in %

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

2024-10-18 00:00:00

News

Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter

Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended Sept...

Read more

2024-10-25 00:00:00

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

2024-10-04 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bliss GVS Pharma Ltd

What is the current PE Ratio of Bliss GVS Pharma Ltd?

The Current PE Ratio of Bliss GVS Pharma Ltd is 16.46 as on 22 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Nov 2024.

What was the PE Ratio of Bliss GVS Pharma Ltd last year?

The PE Ratio of Bliss GVS Pharma Ltd was 10.48 last year, now the PE ratio is 16.46, showing a year-on-year growth of 57.1%.

What does the PE Ratio of Bliss GVS Pharma Ltd indicate about its stock?

The PE Ratio of Bliss GVS Pharma Ltd is 16.46. This ratio indicates that investors are willing to pay 16.46 times the earnings per share for each share of Bliss GVS Pharma Ltd.

What is the PE Ratio Growth of Bliss GVS Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bliss GVS Pharma Ltd grew by 57.1% whereas, the EPS ratio grew by 17.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*